Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
302,717,464
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
140,067,694
-
Shares change
-
+23,790,535
-
Total reported value, excl. options
-
$3,634,026,778
-
Value change
-
+$744,373,801
-
Put/Call ratio
-
1.03%
-
Number of buys
-
99
-
Number of sells
-
-70
-
Price
-
$25.94
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q4 2020
202 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q4 2020.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140,067,694 shares
of 302,717,464 outstanding shares and own 46.27% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (28,504,629 shares), VANGUARD GROUP INC (14,320,299 shares), Jackson Square Partners, LLC (13,474,438 shares), Capital International Investors (9,808,026 shares), SB Management Ltd (9,191,755 shares), Capital World Investors (5,446,000 shares), Nikko Asset Management Americas, Inc. (5,019,138 shares), Casdin Capital, LLC (5,000,000 shares), STATE STREET CORP (4,024,690 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (3,318,740 shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.